• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性感染的囊性纤维化患者对铜绿假单胞菌脂多糖的脂质A、核心多糖和O抗原糖的抗体反应。

Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients.

作者信息

Kronborg G, Fomsgaard A, Galanos C, Freudenberg M A, Høiby N

机构信息

Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.

出版信息

J Clin Microbiol. 1992 Jul;30(7):1848-55. doi: 10.1128/jcm.30.7.1848-1855.1992.

DOI:10.1128/jcm.30.7.1848-1855.1992
PMID:1378455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC265392/
Abstract

Enzyme-linked immunosorbent assays were developed separately for the three main parts of the Pseudomonas aeruginosa lipopolysaccharide (LPS) molecule, namely, lipid A, core, and O polysaccharide. Anti-lipid A, anticore, and anti-O polysaccharide antibodies were measured in serum samples from 12 patients with cystic fibrosis (CF) in a longitudinal study covering the period before P. aeruginosa infection was established through at least 5 years of chronic infection. The serum antibody response to all parts of the P. aeruginosa LPS molecule increased during the course of chronic infection. The increase in anti-lipid A antibodies was specific for P. aeruginosa lipid A, since no increase in anti-Escherichia coli lipid A antibodies was seen. Immunoglobulin G, A, and M (IgG, IgA and IgM) antibodies were all involved in the specific systemic response to P. aeruginosa lipid A, core, and the O polysaccharides. IgG and IgA levels in particular increased during the course of infection and were significantly higher than the antibody increase seen with age in a healthy control group. The local immune response in the lungs was investigated by measuring IgG, IgA, and IgM antibodies to the separate parts of the P. aeruginosa LPS molecule in sputum samples from 18 CF patients with at least a 5-year history of chronic P. aeruginosa infection. Antibodies detected in sputum were mainly anti-lipid A and anti-O polysaccharide antibodies of the IgG and IgA isotypes. Very high IgA anti-lipid A titers were detected in sputum samples from some CF patients.

摘要

针对铜绿假单胞菌脂多糖(LPS)分子的三个主要部分,即脂质A、核心多糖和O多糖,分别开发了酶联免疫吸附测定法。在一项纵向研究中,对12名囊性纤维化(CF)患者的血清样本中的抗脂质A、抗核心多糖和抗O多糖抗体进行了检测,该研究涵盖了从铜绿假单胞菌感染确立前到至少5年慢性感染的时间段。在慢性感染过程中,血清对铜绿假单胞菌LPS分子所有部分的抗体反应均增强。抗脂质A抗体的增加对铜绿假单胞菌脂质A具有特异性,因为未观察到抗大肠杆菌脂质A抗体的增加。免疫球蛋白G、A和M(IgG、IgA和IgM)抗体均参与了对铜绿假单胞菌脂质A、核心多糖和O多糖的特异性全身反应。尤其是IgG和IgA水平在感染过程中升高,且显著高于健康对照组中随年龄增长而出现的抗体增加。通过检测18名有至少5年铜绿假单胞菌慢性感染病史的CF患者痰液样本中针对铜绿假单胞菌LPS分子各部分的IgG、IgA和IgM抗体,研究了肺部的局部免疫反应。痰液中检测到的抗体主要是IgG和IgA亚型的抗脂质A和抗O多糖抗体。在一些CF患者的痰液样本中检测到非常高的IgA抗脂质A滴度。

相似文献

1
Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients.慢性感染的囊性纤维化患者对铜绿假单胞菌脂多糖的脂质A、核心多糖和O抗原糖的抗体反应。
J Clin Microbiol. 1992 Jul;30(7):1848-55. doi: 10.1128/jcm.30.7.1848-1855.1992.
2
Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.脂多糖(LPS)、LPS免疫复合物和细胞因子作为囊性纤维化和慢性铜绿假单胞菌肺部感染患者肺部炎症的诱导剂。
APMIS Suppl. 1995;50:1-30.
3
Specific IgG2 antibodies to Pseudomonas aeruginosa lipid A and lipopolysaccharide are early markers of chronic infection in patients with cystic fibrosis.针对铜绿假单胞菌脂多糖A和脂多糖的特异性IgG2抗体是囊性纤维化患者慢性感染的早期标志物。
Infection. 1993 Sep-Oct;21(5):297-302. doi: 10.1007/BF01712448.
4
Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis.囊性纤维化患者血清中针对洋葱伯克霍尔德菌核心脂多糖抗原的IgG抗体及痰液中的IgA抗体
J Med Microbiol. 1993 Jul;39(1):39-47. doi: 10.1099/00222615-39-1-39.
5
Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.囊性纤维化患者慢性铜绿假单胞菌肺部感染期间对抗脂多糖抗体反应的纵向研究。
Infect Immun. 1988 Sep;56(9):2270-8. doi: 10.1128/iai.56.9.2270-2278.1988.
6
IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis.囊性纤维化患者痰液和血清中针对铜绿假单胞菌表面抗原的IgA和IgG抗体
Acta Pathol Microbiol Scand C. 1979 Jun;87C(3):229-33.
7
Antilipopolysaccharide antibodies and differential diagnosis of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.抗脂多糖抗体与囊性纤维化中慢性铜绿假单胞菌肺部感染的鉴别诊断
J Clin Microbiol. 1989 Jun;27(6):1222-9. doi: 10.1128/jcm.27.6.1222-1229.1989.
8
Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity.囊性纤维化患者中针对铜绿假单胞菌脂多糖的血清型特异性血清IgG抗体:与疾病的相关性、亚类分布及实验性保护能力
Pediatr Res. 1990 May;27(5):508-13. doi: 10.1203/00006450-199005000-00019.
9
Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis.囊性纤维化患者对铜绿假单胞菌藻酸盐的免疫球蛋白A和免疫球蛋白G抗体反应。
J Clin Microbiol. 1990 Apr;28(4):747-55. doi: 10.1128/jcm.28.4.747-755.1990.
10
Anti-LPS IgA and IgG Can Inhibit Serum Killing of Pseudomonas aeruginosa in Patients with Cystic Fibrosis.抗脂多糖 IgA 和 IgG 可抑制囊性纤维化患者血清中铜绿假单胞菌的杀伤作用。
Infect Immun. 2021 Nov 16;89(12):e0041221. doi: 10.1128/IAI.00412-21. Epub 2021 Aug 30.

引用本文的文献

1
De novo mutations mediate phenotypic switching in an opportunistic human lung pathogen.新发突变介导一种机会性人类肺部病原体的表型转换。
Nat Commun. 2025 Jul 23;16(1):6799. doi: 10.1038/s41467-025-61168-4.
2
in chronic lung disease: untangling the dysregulated host immune response.在慢性肺部疾病中:理清失调的宿主免疫反应。
Front Immunol. 2024 Jun 28;15:1405376. doi: 10.3389/fimmu.2024.1405376. eCollection 2024.
3
mutations mediate phenotypic switching in an opportunistic human lung pathogen.突变在一种机会性人类肺部病原体中介导表型转换。
bioRxiv. 2024 Feb 6:2024.02.06.579193. doi: 10.1101/2024.02.06.579193.
4
Secretory Immunoglobulin A Immunity in Chronic Obstructive Respiratory Diseases.慢性阻塞性呼吸道疾病中的分泌型免疫球蛋白 A 免疫。
Cells. 2022 Apr 13;11(8):1324. doi: 10.3390/cells11081324.
5
Immunoglobulin A Mucosal Immunity and Altered Respiratory Epithelium in Cystic Fibrosis.免疫球蛋白 A 黏膜免疫与囊性纤维化中的呼吸道上皮改变。
Cells. 2021 Dec 20;10(12):3603. doi: 10.3390/cells10123603.
6
Potential Therapeutic Targets for Combination Antibody Therapy against Infections.针对感染的联合抗体疗法的潜在治疗靶点
Antibiotics (Basel). 2021 Dec 14;10(12):1530. doi: 10.3390/antibiotics10121530.
7
Lung immunoglobulin A immunity dysregulation in cystic fibrosis.肺免疫球蛋白 A 免疫失调在囊性纤维化中的作用。
EBioMedicine. 2020 Oct;60:102974. doi: 10.1016/j.ebiom.2020.102974. Epub 2020 Sep 11.
8
Dissociation of systemic and mucosal autoimmunity in cystic fibrosis.囊性纤维化中系统性和黏膜自身免疫的分离。
J Cyst Fibros. 2020 Mar;19(2):196-202. doi: 10.1016/j.jcf.2019.06.006. Epub 2019 Jun 28.
9
Dewetting-induced formation and mechanical properties of synthetic bacterial outer membrane models (GUVs) with controlled inner-leaflet lipid composition.具有可控内叶脂质组成的合成细菌外膜模型(巨型单层囊泡)的去湿诱导形成及其力学性能。
Soft Matter. 2019 May 15;15(19):3938-3948. doi: 10.1039/c9sm00223e.
10
Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients.铜绿假单胞菌群体感应与毒力在囊性纤维化肺病患者肺部感染中的作用
PLoS One. 2010 Apr 12;5(4):e10115. doi: 10.1371/journal.pone.0010115.

本文引用的文献

1
Correlation of the biologic responses of C3H/HEJ mice to endotoxin with the chemical and structural properties of the lipopolysaccharides from Pseudomonas aeruginosa and Escherichia coli.C3H/HEJ小鼠对内毒素的生物学反应与铜绿假单胞菌和大肠杆菌脂多糖的化学及结构特性的相关性。
J Immunol. 1981 Jul;127(1):184-91.
2
Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa.脂多糖在铜绿假单胞菌毒力中的作用。
Infect Immun. 1984 May;44(2):508-13. doi: 10.1128/iai.44.2.508-513.1984.
3
Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.从囊性纤维化患者中分离出的铜绿假单胞菌:一类血清敏感、缺乏脂多糖O侧链的不可分型菌株。
Infect Immun. 1983 Oct;42(1):170-7. doi: 10.1128/iai.42.1.170-177.1983.
4
Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa.人对铜绿假单胞菌多糖疫苗免疫反应的特征分析
J Infect Dis. 1983 Aug;148(2):206-13. doi: 10.1093/infdis/148.2.206.
5
Structure of the Core oligosaccharide from the lipopolysaccharide of Pseudomonas aeruginosa PAC1R and its defective mutants.铜绿假单胞菌PAC1R脂多糖核心寡糖的结构及其缺陷突变体
Eur J Biochem. 1983 May 2;132(2):329-37. doi: 10.1111/j.1432-1033.1983.tb07366.x.
6
A new method for the extraction of R lipopolysaccharides.一种提取R脂多糖的新方法。
Eur J Biochem. 1969 Jun;9(2):245-9. doi: 10.1111/j.1432-1033.1969.tb00601.x.
7
Interaction of lipopolysaccharides and lipid A with complement.脂多糖和脂质A与补体的相互作用。
Eur J Biochem. 1971 Mar 1;19(1):143-52. doi: 10.1111/j.1432-1033.1971.tb01298.x.
8
Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa.脂多糖在铜绿假单胞菌调理作用和吞噬作用中的作用。
Infect Immun. 1985 Jul;49(1):182-9. doi: 10.1128/iai.49.1.182-189.1985.
9
Structure and functions of Pseudomonas aeruginosa lipopolysaccharide.
Antibiot Chemother (1971). 1985;36:58-73. doi: 10.1159/000410472.
10
Relevance of vesico-ureteric reflux in development of lipid A antibodies in recurrent urinary tract infections in children--a preliminary study.
Eur J Pediatr. 1987 Jan;146(1):51-5. doi: 10.1007/BF00647284.